Munich, Germany; Atlanta, Georgia - September 10, 2025 – neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and performance, today announced it has ...
The Apollo TMS Therapy product line is FDA-cleared for the treatment of MDD in adult patients who have not had an adequate response to oral antidepressants. It is also FDA-cleared as an adjunctive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback